Review paper

Androgen receptor: A promising therapeutic target in breast cancer

Volume: 56, Issue: 3, Pages: 200 - 223
Published: Mar 1, 2019
Abstract
Breast cancer (BCa) is the second most common cancer worldwide and the most prevalent cancer in women. The majority of BCa cases are positive (+) for the estrogen receptor (ER+, 80%) and progesterone receptor (PR+, 65%). Estrogen and progesterone hormones are known to be involved in cancer progression, and thus hormonal deprivation is used as an effective treatment for ER+PR+ BCa subtypes. However, some ER+PR+ BCa patients develop resistance to...
Paper Details
Title
Androgen receptor: A promising therapeutic target in breast cancer
Published Date
Mar 1, 2019
Volume
56
Issue
3
Pages
200 - 223
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.